[Comparative evaluation of cinoxacin, cotrimoxazole and pipemidic acid in recurrent infections of the lower urinary tract in long-term therapy].
D000328:Adult; D000368:Aged; D002937:Cinoxacin / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010876:Pipemidic Acid / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D012008:Recurrence; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013997:Time Factors; D014295:Trimethoprim / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014552:Urinary Tract Infections / Q000188:drug therapy*
D004338:Drug Combinations; D009539:Nicotinic Acids; D011724:Pyridazines; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole; D002937:Cinoxacin; D010876:Pipemidic Acid
Valutazione comparata di cinoxacina, cotrimossazolo, acido pipemidico nelle infezioni recidivanti delle basse vie urinarie in terapia a lungo termine.